Subscribe to RSSFood And Drug Administration
Watch breaking news videos and read news updates about Food And Drug Administration on FOXBusiness.com.
LATEST VIDEOS
Healthy Foods Driving General Mills
11/17/2009|Web Exclusive
Worldwide Health's Marc Belton on how the focus on nutrition has impacted General Mills.
How to Become a Successful Business Woman
11/03/2009|Opening Bell
Chapman Concierge's Colette Chapman and Count Me In's Nell Merlino on helping women business owners.
Human Genome CEO on Lupus Drug
11/02/2009|Closing Bell
Human Genome Sciences CEO Tom Watkins on its new lupus drug.
Market to See Greater Recovery in 2010
10/28/2009|Opening Bell
FTN Equity Capital's Tony Dwyer argues we are in a V-shaped recovery.
Anti-Obesity activist MeMe Roth breaks down why the government is cracking down on 'healthy' foods.
Currency Comptroller on Financials
10/26/2009|FOX Business
Comptroller of the Currency John Dugan on why big banks are necessary.
The Benefits of 'High'er Education
10/23/2009|FOX Business
Oaksterdam University's Dale Clare on training people for the marijuana industry.
Drug Czar Against Legalizing Med. Marijuana
10/22/2009|FOX Business
Office of National Drug Control's Gil Kerlikowske on legalizing medical marijuana.
Suzanne Somers on Cancer Treatments
10/21/2009|Cavuto
Actress and cancer survivor Suzanne Somers on treatment options for cancer patients
Many Pot Dispensaries Operating Illegally
10/21/2009|FOX Business
Attorney David Berger argues many medical marijuana dispensaries operate illegally for profit.
LATEST STORIES
AstraZeneca Submits Brilinta NDA To FDA
| MarketWatch Pulse| Markets
… LONDON -- Drugmaker AstraZeneca said Thursday that it has submitted a new drug application to the U.S. Food and Drug Administration for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac …
Story|11/19/2009
Vivus Shares Rise on Erectile Dysfunction Drug Success
| FOXBusiness| Markets
… was effective in a late stage trial, putting the biotech firm on course to file an application with the Food and Drug Administration in 2011. The shares were up about 3% in late afternoon trading. Vivus Chief Executive Leland Wilson said …
Story|11/18/2009
FDA Warns Against Taking Plavix With Prilosec
| MarketWatch Pulse| Markets
… By Val Brickates Kennedy MarketWatch Pulse BOSTON -- The Food and Drug Administration warned Tuesday that taking the blood-thinner Plavix with ..... felbamate, fluoxetine, fluvoxamine, and ticlopidine. The FDA warned patients at risk for heart attack or stroke taking …
Story|11/17/2009
Early-Market Movers: Semitool, Cerus
| FOXBusiness| Markets
… the year. NeurogesX Inc. (NGSX) The biopharmaceutical company announced its pain treatment, Qutenza, was approved by the FDA to treat nerve pain resulting from an outbreak of shingles. Shares gained 16% in pre-market trading on the news. BluePhoenix …
Story|11/17/2009
Covidien Quarterly Net Income Drops 86%
| MarketWatch Pulse| Markets
… fiscal 2010 sales guidance to reflect the recent weakening of the U.S. dollar, the acquisition of Aspect Medical Systems and FDA approvals of Oral Transmucosal Fentanyl Citrate and Pennsaid. It now expects sales growth in a range of 6% to 9%. Copyright …
Story|11/17/2009
Roche Unit Files For 2 FDA Clearances For Avastin
| MarketWatch Pulse| Markets
… subsidiary of Roche , the Basel health-care giant, said on Tuesday that it submitted to the U.S. Food and Drug Administration two applications to market Avastin to treat women who have not received chemotherapy for advanced HER2 …
Story|11/17/2009
FDA Finds Deficiencies at Genzyme's Lumizyme Plant
| FOXBusiness| Markets
… release from the company. Genzyme will request a meeting with the FDA to determine the quickest way to gain approval for Lumizyme ..... in operation, and we will continue to work closely with the FDA to resolve these issues,” said Genzyme Chairman and Chief Executive …
Story|11/16/2009
CombinatoRx Shares Fall as Neuromed Drug Not Approved by FDA
| FOXBusiness| Markets
… of CombinatoRx fell when it announced Neuromed, with which it has a merger pending, will have to resubmit for FDA approval of its pain drug Exalgo.
Story|11/16/2009
NeurogesX Wins FDA OK For Pain Treatment Qutenza
| MarketWatch Pulse| Markets
… its pain treatment, Qutenza, was approved by the U.S. Food and Drug Administration . The dermal patch uses a high-concentration dose of synthetic ..... follow an outbreak of shingles. The product approval by the FDA is the first for San Mateo, Calif.-based NeurogesX …
Story|11/16/2009
Market Winners & Losers: Abercrombie & Fitch, Genzyme
| FOXBusiness| Markets
… gain of $3.23 on the day. Losers Genzyme Corp. (GENZ) The pharmaceutical company saw its stock sink 7.3% after the FDA discovered some of its drugs contain contaminants. GENZ shares closed at $49.28, a loss of $3.89 on the day. MBIA Inc …
Story|11/13/2009
